Adult Malignant Mesenchymoma
5 clinical trials · Condition
◉ Watch Adult Malignant Mesenchymoma
| Record | Firm | Date |
|---|---|---|
| Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma (NCT01154452) | National Cancer Institute (NCI) | 2010-06-01 |
| Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma (NCT00720174) | National Cancer Institute (NCI) | 2008-06-01 |
| Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma (NCT00346164) | Children's Oncology Group | 2007-02-05 |
| Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma (NCT00112463) | National Cancer Institute (NCI) | 2005-01-07 |
| Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma (NCT00003958) | Children's Oncology Group | 2002-09-01 |
Track Adult Malignant Mesenchymoma automatically
Every clearance here is in the API, with alerts when new ones post.